Last Updated : March 27, 2006
Details
FilesGeneric Name:
Alendronate sodium/cholecalciferol
Project Status:
Complete
Therapeutic Area:
Osteoporosis
Manufacturer:
Merck Frosst Canda Ltd.
Brand Name:
Fosavance
Project Line:
Reimbursement Review
Project Number:
SR0059-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Osteoporosis
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : March 27, 2006